Genprex Inc Share Price - GNPX | ADVFN (2024)

`,data() {return {tabs: [] };},created() {this.tabs = this.$children;},methods: {selectTab(selectedTab) {this.tabs.forEach(tab => {tab.isActive = (tab.name == selectedTab.name);});}}});Vue.component('tab', {template: `

`,props: {name: { required: true },selected: { default: false}},data() {return {isActive: false};},computed: {href() {return '#' + this.name.toLowerCase().replace(/ /g, '-');}},mounted() {this.isActive = this.selected;}});Vue.component('newslist', {template: `

`,props: {source: { required: true },rawarticles: { required: true },limit: { default: 12 }},methods: {processData: function(articles){if(articles.length > this.limit){articles = articles.slice(0, this.limit);}this.articles = articles;this.loaded = true;Vue.nextTick(function(){});},stripRedudancies: function(articles){return _.uniqBy(articles, "headline");}},data() {return {loaded: false,articles: []};},mounted() {this.processData(this.rawarticles);}});new Vue({el: '#nw-news-widget',data: {loaded: false,availableTabs: {"Press Releases": [{"headline":"Form 424B5 - Prospectus [Rule 424(b)(5)]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93892025\/form-424b5-prospectus-rule-424b5","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1716237351,"date":"Mon May 20, 2024 ","time":"4:35 PM (1 week ago)","full_date":"May 20, 2024 4:35 PM","post_time":"May 20 2024","article_id":93892025,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93860553\/form-10-q-quarterly-report-sections-13-or-15d","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715804154,"date":"Wed May 15, 2024 ","time":"4:15 PM (2 weeks ago)","full_date":"May 15, 2024 4:15 PM","post_time":"May 15 2024","article_id":93860553,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa\u00ae Immunogene Therapy in Combination with Tecentriq\u00ae to Treat Small Cell Lung Cancer","short_text":" Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa\u00ae Immunogene Therapy in Combination with Tecentriq\u00ae to Treat Small Cell Lung Cancer\nPR Newswire\nAUSTIN, Texas, May 14, 2024...","one_line_short_text":" Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa\u00ae Immunogene Therapy in Combination with Tecentriq\u00ae to Treat Small Cell Lung...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93845423\/genprex-doses-first-patient-in-acclaim-3-clinical","source":"PR Newswire (US)","source_logo":"\/common\/images\/news-sources\/prnus.png","tags":[],"timestamp":1715689860,"date":"Tue May 14, 2024 ","time":"8:31 AM (2 weeks ago)","full_date":"May 14, 2024 8:31 AM","post_time":"May 14 2024","article_id":93845423,"source_id":"prnus","media_url":null,"press_release":true},{"headline":"Genprex Announces the Appointment of Jose A. Moreno Toscano as Chairman of the Board of Directors","short_text":" Genprex Announces the Appointment of Jose A. Moreno Toscano as Chairman of the Board of Directors\nPR Newswire\nAUSTIN, Texas, May 13, 2024 Follows the Recent Appointment of Ryan Confer as Genprex...","one_line_short_text":" Genprex Announces the Appointment of Jose A. Moreno Toscano as Chairman of the Board of Directors\nPR Newswire\nAUSTIN, Texas, May 13, 2024 Follows...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93834884\/genprex-announces-the-appointment-of-jose-a-moren","source":"PR Newswire (US)","source_logo":"\/common\/images\/news-sources\/prnus.png","tags":[],"timestamp":1715603460,"date":"Mon May 13, 2024 ","time":"8:31 AM (2 weeks ago)","full_date":"May 13, 2024 8:31 AM","post_time":"May 13 2024","article_id":93834884,"source_id":"prnus","media_url":null,"press_release":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93814538\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715256667,"date":"Thu May 09, 2024 ","time":"8:11 AM (3 weeks ago)","full_date":"May 9, 2024 8:11 AM","post_time":"May 09 2024","article_id":93814538,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner","short_text":" Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner\nPR Newswire\nAUSTIN, Texas, May 8, 2024 Ryan Confer Appointed Genprex President and CEO and to its Board...","one_line_short_text":" Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner\nPR Newswire\nAUSTIN, Texas, May 8, 2024 Ryan Confer...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93808405\/genprex-announces-the-passing-of-its-co-founder-an","source":"PR Newswire (US)","source_logo":"\/common\/images\/news-sources\/prnus.png","tags":[],"timestamp":1715206080,"date":"Wed May 08, 2024 ","time":"6:08 PM (3 weeks ago)","full_date":"May 8, 2024 6:08 PM","post_time":"May 08 2024","article_id":93808405,"source_id":"prnus","media_url":null,"press_release":true},{"headline":"Genprex to Present and Participate at Upcoming May Investor and Industry Conferences","short_text":" Genprex to Present and Participate at Upcoming May Investor and Industry Conferences\nPR Newswire\nAUSTIN, Texas, May. 1, 2024 AUSTIN, Texas, May. 1, 2024 \/PRNewswire\/ -- Genprex, Inc. (\"Genprex...","one_line_short_text":" Genprex to Present and Participate at Upcoming May Investor and Industry Conferences\nPR Newswire\nAUSTIN, Texas, May. 1, 2024 AUSTIN, Texas, May...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93760052\/genprex-to-present-and-participate-at-upcoming-may","source":"PR Newswire (US)","source_logo":"\/common\/images\/news-sources\/prnus.png","tags":[],"timestamp":1714566660,"date":"Wed May 01, 2024 ","time":"8:31 AM (4 weeks ago)","full_date":"May 1, 2024 8:31 AM","post_time":"May 01 2024","article_id":93760052,"source_id":"prnus","media_url":null,"press_release":true},{"headline":"Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa\u00ae and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex\u00ae Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting","short_text":" Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa\u00ae and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex\u00ae Delivery System for the Treatment of Lung Cancers at the 2024...","one_line_short_text":" Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa\u00ae and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex\u00ae Delivery...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93624959\/genprex-collaborators-report-positive-preclinical","source":"PR Newswire (US)","source_logo":"\/common\/images\/news-sources\/prnus.png","tags":[],"timestamp":1712665860,"date":"Tue Apr 09, 2024 ","time":"8:31 AM (2 months ago)","full_date":"April 9, 2024 8:31 AM","post_time":"April 09 2024","article_id":93624959,"source_id":"prnus","media_url":null,"press_release":true},{"headline":"Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa\u00ae Therapy in Combination with Tecentriq\u00ae to Treat Small Cell Lung Cancer","short_text":" Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa\u00ae Therapy in Combination with Tecentriq\u00ae to Treat Small Cell Lung Cancer\nPR Newswire\nAUSTIN, Texas, April 3, 2024...","one_line_short_text":" Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa\u00ae Therapy in Combination with Tecentriq\u00ae to Treat Small Cell Lung...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93598745\/genprex-expands-clinical-trial-sites-for-acclaim-3","source":"PR Newswire (US)","source_logo":"\/common\/images\/news-sources\/prnus.png","tags":[],"timestamp":1712147460,"date":"Wed Apr 03, 2024 ","time":"8:31 AM (2 months ago)","full_date":"April 3, 2024 8:31 AM","post_time":"April 03 2024","article_id":93598745,"source_id":"prnus","media_url":null,"press_release":true},{"headline":"Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex\u00ae Delivery System","short_text":" Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex\u00ae Delivery System\nPR Newswire\nAUSTIN, Texas, April 2, 2024 NPRL2 Gene Therapy Induces Anti-Tumor...","one_line_short_text":" Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex\u00ae Delivery System\nPR Newswire\nAUSTIN, Texas...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93590057\/genprex-collaborators-publish-positive-preclinical","source":"PR Newswire (US)","source_logo":"\/common\/images\/news-sources\/prnus.png","tags":[],"timestamp":1712061060,"date":"Tue Apr 02, 2024 ","time":"8:31 AM (2 months ago)","full_date":"April 2, 2024 8:31 AM","post_time":"April 02 2024","article_id":93590057,"source_id":"prnus","media_url":null,"press_release":true},{"headline":"Genprex Announces Closing of $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules","short_text":" Genprex Announces Closing of $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules\nPR Newswire\nAUSTIN, Texas, March 22, 2024 AUSTIN, Texas, March 22, 2024 \/PRNewswire\/...","one_line_short_text":" Genprex Announces Closing of $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules\nPR Newswire\nAUSTIN, Texas, March 22...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93536928\/genprex-announces-closing-of-6-5-million-register","source":"PR Newswire (US)","source_logo":"\/common\/images\/news-sources\/prnus.png","tags":[],"timestamp":1711138200,"date":"Fri Mar 22, 2024 ","time":"4:10 PM (2 months ago)","full_date":"March 22, 2024 4:10 PM","post_time":"March 22 2024","article_id":93536928,"source_id":"prnus","media_url":null,"press_release":true},{"headline":"Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules","short_text":" Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules\nPR Newswire\nAUSTIN, Texas, March 19, 2024 AUSTIN, Texas, March 19, 2024 \/PRNewswire\/ -- Genprex...","one_line_short_text":" Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules\nPR Newswire\nAUSTIN, Texas, March 19, 2024...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93516208\/genprex-announces-6-5-million-registered-direct-o","source":"PR Newswire (US)","source_logo":"\/common\/images\/news-sources\/prnus.png","tags":[],"timestamp":1710869040,"date":"Tue Mar 19, 2024 ","time":"1:24 PM (2 months ago)","full_date":"March 19, 2024 1:24 PM","post_time":"March 19 2024","article_id":93516208,"source_id":"prnus","media_url":null,"press_release":true}],"All News": [{"headline":"Form 424B5 - Prospectus [Rule 424(b)(5)]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93892025\/form-424b5-prospectus-rule-424b5","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1716237351,"date":"Mon May 20, 2024 ","time":"4:35 PM (1 week ago)","full_date":"May 20, 2024 4:35 PM","post_time":"May 20 2024","article_id":93892025,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93860553\/form-10-q-quarterly-report-sections-13-or-15d","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715804154,"date":"Wed May 15, 2024 ","time":"4:15 PM (2 weeks ago)","full_date":"May 15, 2024 4:15 PM","post_time":"May 15 2024","article_id":93860553,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa\u00ae Immunogene Therapy in Combination with Tecentriq\u00ae to Treat Small Cell Lung Cancer","short_text":" Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa\u00ae Immunogene Therapy in Combination with Tecentriq\u00ae to Treat Small Cell Lung Cancer\nPR Newswire\nAUSTIN, Texas, May 14, 2024...","one_line_short_text":" Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa\u00ae Immunogene Therapy in Combination with Tecentriq\u00ae to Treat Small Cell Lung...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93845423\/genprex-doses-first-patient-in-acclaim-3-clinical","source":"PR Newswire (US)","source_logo":"\/common\/images\/news-sources\/prnus.png","tags":[],"timestamp":1715689860,"date":"Tue May 14, 2024 ","time":"8:31 AM (2 weeks ago)","full_date":"May 14, 2024 8:31 AM","post_time":"May 14 2024","article_id":93845423,"source_id":"prnus","media_url":null,"press_release":true},{"headline":"Genprex Announces the Appointment of Jose A. Moreno Toscano as Chairman of the Board of Directors","short_text":" Genprex Announces the Appointment of Jose A. Moreno Toscano as Chairman of the Board of Directors\nPR Newswire\nAUSTIN, Texas, May 13, 2024 Follows the Recent Appointment of Ryan Confer as Genprex...","one_line_short_text":" Genprex Announces the Appointment of Jose A. Moreno Toscano as Chairman of the Board of Directors\nPR Newswire\nAUSTIN, Texas, May 13, 2024 Follows...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93834884\/genprex-announces-the-appointment-of-jose-a-moren","source":"PR Newswire (US)","source_logo":"\/common\/images\/news-sources\/prnus.png","tags":[],"timestamp":1715603460,"date":"Mon May 13, 2024 ","time":"8:31 AM (2 weeks ago)","full_date":"May 13, 2024 8:31 AM","post_time":"May 13 2024","article_id":93834884,"source_id":"prnus","media_url":null,"press_release":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93814538\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715256667,"date":"Thu May 09, 2024 ","time":"8:11 AM (3 weeks ago)","full_date":"May 9, 2024 8:11 AM","post_time":"May 09 2024","article_id":93814538,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner","short_text":" Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner\nPR Newswire\nAUSTIN, Texas, May 8, 2024 Ryan Confer Appointed Genprex President and CEO and to its Board...","one_line_short_text":" Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner\nPR Newswire\nAUSTIN, Texas, May 8, 2024 Ryan Confer...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93808405\/genprex-announces-the-passing-of-its-co-founder-an","source":"PR Newswire (US)","source_logo":"\/common\/images\/news-sources\/prnus.png","tags":[],"timestamp":1715206080,"date":"Wed May 08, 2024 ","time":"6:08 PM (3 weeks ago)","full_date":"May 8, 2024 6:08 PM","post_time":"May 08 2024","article_id":93808405,"source_id":"prnus","media_url":null,"press_release":true},{"headline":"Genprex to Present and Participate at Upcoming May Investor and Industry Conferences","short_text":" Genprex to Present and Participate at Upcoming May Investor and Industry Conferences\nPR Newswire\nAUSTIN, Texas, May. 1, 2024 AUSTIN, Texas, May. 1, 2024 \/PRNewswire\/ -- Genprex, Inc. (\"Genprex...","one_line_short_text":" Genprex to Present and Participate at Upcoming May Investor and Industry Conferences\nPR Newswire\nAUSTIN, Texas, May. 1, 2024 AUSTIN, Texas, May...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93760052\/genprex-to-present-and-participate-at-upcoming-may","source":"PR Newswire (US)","source_logo":"\/common\/images\/news-sources\/prnus.png","tags":[],"timestamp":1714566660,"date":"Wed May 01, 2024 ","time":"8:31 AM (4 weeks ago)","full_date":"May 1, 2024 8:31 AM","post_time":"May 01 2024","article_id":93760052,"source_id":"prnus","media_url":null,"press_release":true},{"headline":"Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa\u00ae and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex\u00ae Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting","short_text":" Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa\u00ae and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex\u00ae Delivery System for the Treatment of Lung Cancers at the 2024...","one_line_short_text":" Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa\u00ae and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex\u00ae Delivery...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93624959\/genprex-collaborators-report-positive-preclinical","source":"PR Newswire (US)","source_logo":"\/common\/images\/news-sources\/prnus.png","tags":[],"timestamp":1712665860,"date":"Tue Apr 09, 2024 ","time":"8:31 AM (2 months ago)","full_date":"April 9, 2024 8:31 AM","post_time":"April 09 2024","article_id":93624959,"source_id":"prnus","media_url":null,"press_release":true},{"headline":"Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa\u00ae Therapy in Combination with Tecentriq\u00ae to Treat Small Cell Lung Cancer","short_text":" Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa\u00ae Therapy in Combination with Tecentriq\u00ae to Treat Small Cell Lung Cancer\nPR Newswire\nAUSTIN, Texas, April 3, 2024...","one_line_short_text":" Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa\u00ae Therapy in Combination with Tecentriq\u00ae to Treat Small Cell Lung...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93598745\/genprex-expands-clinical-trial-sites-for-acclaim-3","source":"PR Newswire (US)","source_logo":"\/common\/images\/news-sources\/prnus.png","tags":[],"timestamp":1712147460,"date":"Wed Apr 03, 2024 ","time":"8:31 AM (2 months ago)","full_date":"April 3, 2024 8:31 AM","post_time":"April 03 2024","article_id":93598745,"source_id":"prnus","media_url":null,"press_release":true},{"headline":"Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex\u00ae Delivery System","short_text":" Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex\u00ae Delivery System\nPR Newswire\nAUSTIN, Texas, April 2, 2024 NPRL2 Gene Therapy Induces Anti-Tumor...","one_line_short_text":" Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex\u00ae Delivery System\nPR Newswire\nAUSTIN, Texas...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93590057\/genprex-collaborators-publish-positive-preclinical","source":"PR Newswire (US)","source_logo":"\/common\/images\/news-sources\/prnus.png","tags":[],"timestamp":1712061060,"date":"Tue Apr 02, 2024 ","time":"8:31 AM (2 months ago)","full_date":"April 2, 2024 8:31 AM","post_time":"April 02 2024","article_id":93590057,"source_id":"prnus","media_url":null,"press_release":true},{"headline":"Genprex Announces Closing of $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules","short_text":" Genprex Announces Closing of $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules\nPR Newswire\nAUSTIN, Texas, March 22, 2024 AUSTIN, Texas, March 22, 2024 \/PRNewswire\/...","one_line_short_text":" Genprex Announces Closing of $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules\nPR Newswire\nAUSTIN, Texas, March 22...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93536928\/genprex-announces-closing-of-6-5-million-register","source":"PR Newswire (US)","source_logo":"\/common\/images\/news-sources\/prnus.png","tags":[],"timestamp":1711138200,"date":"Fri Mar 22, 2024 ","time":"4:10 PM (2 months ago)","full_date":"March 22, 2024 4:10 PM","post_time":"March 22 2024","article_id":93536928,"source_id":"prnus","media_url":null,"press_release":true},{"headline":"Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules","short_text":" Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules\nPR Newswire\nAUSTIN, Texas, March 19, 2024 AUSTIN, Texas, March 19, 2024 \/PRNewswire\/ -- Genprex...","one_line_short_text":" Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules\nPR Newswire\nAUSTIN, Texas, March 19, 2024...","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/genprex-GNPX\/stock-news\/93516208\/genprex-announces-6-5-million-registered-direct-o","source":"PR Newswire (US)","source_logo":"\/common\/images\/news-sources\/prnus.png","tags":[],"timestamp":1710869040,"date":"Tue Mar 19, 2024 ","time":"1:24 PM (2 months ago)","full_date":"March 19, 2024 1:24 PM","post_time":"March 19 2024","article_id":93516208,"source_id":"prnus","media_url":null,"press_release":true}],"Preferred Contributors": ""}},created: function () {this.loaded = true;Vue.nextTick(function(){});}});});

Latest GNPX Messages

{{bbMessage.M_Alias}}{{bbMessage.MSG_Date}}{{bbMessage.HowLongAgo}}{{bbMessage.MSG_ID}}{{bbMessage.MSG_Subject}} Share on Facebook Share on Twitter Share on Email

Loading Messages....

No posts yet, be the first!No GNPX Message Board. Create One!See More Posts on GNPX Message BoardSee More Message Board Posts

Genprex Description